Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | 74,692 | reported | 30 Mar 2015 | tx 11+133,612−17,224 |
| Sucampo Pharmaceuticals, Inc. | 0 | reported | 13 Feb 2018 | tx 4+5,139−155,139 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 13 Feb 2018 | OTHER | Sucampo Pharmaceuticals, Inc. | 5,139 | 18.00 USD | |
| 13 Feb 2018 | OTHER | Sucampo Pharmaceuticals, Inc. | 150,000 | 7.10 USD | deriv |
| 31 Dec 2017 | GRANT_AWARD | Sucampo Pharmaceuticals, Inc. | 439 | 10.24 USD | |
| 04 Aug 2017 | PURCHASE | Sucampo Pharmaceuticals, Inc. | 4,700 | 10.60 USD | |
| 30 Mar 2015 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 6,712 | 12.02 USD | |
| 30 Mar 2015 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 6,712 | 2.56 USD | |
| 30 Mar 2015 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 6,712 | 0.00 USD | deriv |
| 24 Mar 2015 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 1,875 | 3.36 USD | |
| 24 Mar 2015 | SALE | SUPERNUS PHARMACEUTICALS, INC. | 1,900 | 12.00 USD | |
| 24 Mar 2015 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 25 | 2.56 USD | |
| 24 Mar 2015 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 1,875 | 0.00 USD | deriv |
| 24 Mar 2015 | EXERCISE | SUPERNUS PHARMACEUTICALS, INC. | 25 | 0.00 USD | deriv |
| 03 Mar 2015 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 25,000 | 0.00 USD | deriv |
| 21 Jan 2014 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 30,000 | 0.00 USD | deriv |
| 05 Feb 2013 | GRANT_AWARD | SUPERNUS PHARMACEUTICALS, INC. | 70,000 | 0.00 USD | deriv |